As she investigates cancer treatments and pursues her own path toward becoming a physician-scientist, the Brown University ...

A team led by researchers at the University of Toronto has uncovered new targets that could be the key to effectively treating glioblastoma, a lethal type of brain cancer. These targets were ...

Researchers at the Joint Department of Biomedical Engineering at UNC and North Carolina State University recently received a $3.15 million grant from the National Cancer Institute.

A team led by researchers at the University of Toronto has uncovered new targets that could be the key to effectively treating glioblastoma, a lethal type of brain cancer. The targets were identified ...

A team led by researchers at the University of Toronto has uncovered new targets that could be the key to effectively ...

Gliocidin selectively kills glioblastoma cells by inhibiting nucleotide synthesis, showing potential as a therapeutic option ...

A new study identifies key genetic vulnerabilities in glioblastoma stem cells, revealing subtype-specific dependencies that ...

Announced FDA Clearance of the Northwestern University IND Application for NeuroNova (CLD-101) Clinical Trial in High-Grade Glioma.Presented data ...

Six main cell types form glioblastomas (GBM), the most aggressive brain cancer due to its high rate of recurrence. Of these six, quiescent cancer stem cells are responsible for resistance to therapy ...

匹兹堡大学医学中心Jeremy Rich教授团队在Cell Metabolism杂志上发表了题为Metabolic regulation of the glioblastoma stem cell epitranscriptome by malate dehydrogenase 2的论文。

It is also the most challenging to treat due to the resistance of glioblastoma cancer stem cells, from which tumors grow, to therapy. Cancer stem cells that survive after a tumor is treated go on ...